Zobrazeno 1 - 10
of 278
pro vyhledávání: '"Philip J. Disaia"'
Autor:
Larry J. Copeland, Mark F. Brady, Robert A. Burger, William H. Rodgers, Helen Q. Huang, David Cella, David M. O'Malley, Daron G. Street, Krishnansu S. Tewari, David P. Bender, Robert T. Morris, William J. Lowery, David S. Miller, Summer B. Dewdney, Nick M. Spirtos, Shashikant B. Lele, Saketh Guntupalli, Frederick R. Ueland, Gretchen E. Glaser, Robert S. Mannel, Philip J. DiSaia
Publikováno v:
Journal of Clinical Oncology. 40:4119-4128
PURPOSE To compare taxane maintenance chemotherapy, paclitaxel (P) and paclitaxel poliglumex (PP), with surveillance (S) in women with ovarian, peritoneal, or fallopian tube (O/PC/FT) cancer who attained clinical complete response after first-line pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703d9b1ede924d762a06acf7ea13d7aa
https://doi.org/10.1200/jco.22.00146
https://doi.org/10.1200/jco.22.00146
Autor:
Barbara M. Norquist, Danielle Enserro, Bradley J. Monk, Michael A. Bookman, Matthew P. Boente, John K. Chan, Robert L. Coleman, Robert A. Burger, Michael J. Birrer, Philip J. DiSaia, Thomas J. Herzog, Krishnansu S. Tewari, Benjamin E. Greer, Helen Q. Huang, Howard D. Homesley, Elizabeth M. Swisher, Carlos Bais, Mark F. Brady, Leslie M. Randall, C. Ye, Larry J. Copeland, Sharon X. Liang, J. Stuart Ferriss, Carol Aghajanian, Robert S. Mannel, Gini F. Fleming, Jeffrey M. Fowler
Publikováno v:
J Clin Oncol
PURPOSE We report the final, protocol-specified analysis of overall survival (OS) in GOG-0218, a phase III, randomized trial of bevacizumab in women with newly diagnosed ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS A total of 1,8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca405a5ed9df8156bdd64185764ea1e
https://doi.org/10.1200/jco.19.01009
https://doi.org/10.1200/jco.19.01009
Autor:
Helen Huang, Katherine Y. Look, J. Tate Thigpen, Bradley J. Monk, Wui Jin Koh, William T. Creasman, Ana Oaknin, Robert A. Burger, Thomas J. Reid, Frederick B. Stehman, Steven E Waggoner, Lisa M. Landrum, David H. Moore, Michael J. Birrer, Lois M. Ramondetta, Philip J. DiSaia, Michael W. Sill, Richard T. Penson, Helen Michael, Mark F. Brady, Mario M. Leitao, Krishnansu S. Tewari, Larry J. Copeland
Publikováno v:
Tewari, KS; Sill, MW; Penson, RT; Huang, H; Ramondetta, LM; Landrum, LM; et al.(2017). Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). The Lancet, 390(10103), 1654-1663. doi: 10.1016/S0140-6736(17)31607-0. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2rq1s1px
© 2017 Elsevier Ltd Background On Aug 14, 2014, the US Food and Drug Administration approved the antiangiogenesis drug bevacizumab for women with advanced cervical cancer on the basis of improved overall survival (OS) after the second interim analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa844c008d4a130ad4f47c1cf0f5b55
https://doi.org/10.1016/s0140-6736(17)31607-0
https://doi.org/10.1016/s0140-6736(17)31607-0
Autor:
Philip J. DiSaia, Marcia Batista Salzgeber, Ismael Dcg Silva, Manoel Jbc Girão, Robert A. Nagourney, Robert E. Bristow, Paulo D'Amora, Steven S. Evans
Publikováno v:
Tumor Microenvironment and Models of Ovarian Cancer.
INTRODUCTION: Personalized oncology has advanced through the application of genomic, transcriptomics & proteomic platforms. BCR-abl; EGFr & ALK have provided drug-able targets & companion diagnostics in several diseases, yet many human transforming e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89f91c0591abbcd90cc496b5e2b67c7c
https://doi.org/10.1158/1557-3265.ovcasymp16-tmem-021
https://doi.org/10.1158/1557-3265.ovcasymp16-tmem-021
Autor:
Ramez N. Eskander, Philip J. DiSaia
Publikováno v:
Current Angiogenesis. 1:266-276
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b47b0ca546dca1bdb3b9e60ec0f3cb6
https://doi.org/10.2174/2211552811201040266
https://doi.org/10.2174/2211552811201040266
Autor:
Philip J. DiSaia, Robert E. Bristow, Michael L. Berman, Ramez N. Eskander, Leslie M. Randall, Krishnansu S. Tewari
Publikováno v:
Eskander, RN; Randall, LM; Berman, ML; Tewari, KS; Disaia, PJ; & Bristow, RE. (2011). Fertility preserving options in patients with gynecologic malignancies. American Journal of Obstetrics and Gynecology, 205(2), 103-110. doi: 10.1016/j.ajog.2011.01.025. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/53h147x5
A proportion of reproductive age women are affected by gynecologic malignancies. This patient population is faced with difficult decisions, related to their cancer care and treatment, as well as future childbearing potential. Therefore, it is importa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eacbd829620664cbb74c6fd620bad5f5
https://doi.org/10.1016/j.ajog.2011.01.025
https://doi.org/10.1016/j.ajog.2011.01.025
Publikováno v:
American Journal of Obstetrics and Gynecology. 200:472-480
The rates of cervical cancer in the United States are low in comparison with developing nations. Whereas the Papanicolaou smear has performed well in terms of dectecting both precursors of squamous cell carcinoma and squamous cell carcinoma of the ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6edb316bffc8e1c02933aa6e32132bc1
https://doi.org/10.1016/j.ajog.2008.12.025
https://doi.org/10.1016/j.ajog.2008.12.025
Publikováno v:
Gynecologic Oncology. 113:52-56
To determine if low node count from superficial groin dissection correlated with first recurrence in the groin for patients with early vulvar cancer.The Gynecologic Oncology Group (GOG) conducted a trial for patients with early stage squamous vulvar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b83bd3076d3729adea4f9615abe549d
https://doi.org/10.1016/j.ygyno.2008.12.028
https://doi.org/10.1016/j.ygyno.2008.12.028
Autor:
Michael A. Quinn, Edward L. Trimble, Philip J. DiSaia, J. A Davis, Gunnar B. Kristensen, Jacobus Pfisterer, Nicholas S imon Reed, David K. Gaffney, Keiichi Fujiwara, J. T. Thigpen, Mason Schoenfeldt, Jonathan A. Ledermann
Publikováno v:
International Journal of Gynecological Cancer. 17:547-556
The Gynecologic Cancer Intergroup is comprised representatives from international gynecological cancer trials organizations, which collaborate in multicenter studies to answer the clinical challenges in gynecological cancer. This review article highl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbca49126ddaf9612fc756131b82a65a
https://doi.org/10.1111/j.1525-1438.2007.00667.x
https://doi.org/10.1111/j.1525-1438.2007.00667.x
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer
Autor:
Alessandra Magistris, Philip J. DiSaia, Joanne Rutgers, Vera Loizzi, John K. Chan, Fritz Lin, Kathryn Osann, Michael Samoszuk
Publikováno v:
Gynecologic Oncology. 99:20-25
Objective. To determine clinical or biological associations between mast cell density, blood clotting, angiogenesis, and survival of patients with advanced ovarian cancer. Methods. Tumor tissue sections were assessed for mast cell density by staining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc2ef070b8d60182d26b2476c66070e
https://doi.org/10.1016/j.ygyno.2005.05.042
https://doi.org/10.1016/j.ygyno.2005.05.042